These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7107791)

  • 1. High-performance liquid chromatographic analysis of propafenone in human plasma samples.
    Harapat SR; Kates RE
    J Chromatogr; 1982 Jul; 230(2):448-53. PubMed ID: 7107791
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of cardiac arrhythmias in the aged and their treatment with propafenone controlled by plasma level].
    Lachnit KS; Rieder L
    Z Gerontol; 1985; 18(6):343-52. PubMed ID: 2420079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propafenone.
    Brodsky MA; Allen BJ
    Chest; 1985 Aug; 88(2):164-5. PubMed ID: 4017666
    [No Abstract]   [Full Text] [Related]  

  • 4. Propafenone: a new agent for ventricular arrhythmia.
    Podrid PJ; Lown B
    J Am Coll Cardiol; 1984 Jul; 4(1):117-25. PubMed ID: 6376591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Propafenone--a new antiarrhythmic agent. Clinical experience].
    Kozák P; Stárek A; Hes I; Spacek R
    Cas Lek Cesk; 1985 Mar; 124(13):407-10. PubMed ID: 3891090
    [No Abstract]   [Full Text] [Related]  

  • 6. [The anti-arrhythmic effects and electrophysiological actions of propafenone].
    Zheng DS; Wang BY
    Zhonghua Yi Xue Za Zhi; 1985 Jul; 65(7):418-20. PubMed ID: 3938327
    [No Abstract]   [Full Text] [Related]  

  • 7. [Oral propafenone in chronic ventricular arrhythmias. Prospective evaluation with the Holter monitor].
    Sánchez Domínguez J; Roldán I; Navarro A; Villa JG; Urbina FJ; Barciela R; Barras C
    Rev Clin Esp; 1985 Nov; 177(8):372-5. PubMed ID: 3836459
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience with the antiarrhythmic propafenone (Rytmonorm)].
    Stejfa M; Spác J; Vítovec J; Havlát F
    Vnitr Lek; 1986 Apr; 32(4):393-7. PubMed ID: 3523975
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-arrhythmic effects of propafenone in coronary patients with ventricular arrhythmias].
    Fiol M; Palma JL; Bayés de Luna A; Aza V; Sadurní J
    Rev Esp Cardiol; 1984; 37(3):196-200. PubMed ID: 6505351
    [No Abstract]   [Full Text] [Related]  

  • 10. [Oral propafenone in the long-term treatment of chronic ventricular arrhythmia].
    Vázquez García A; Marcos Sánchez F; Górgolas Hernández-Mora P; Durán Pérez-Navarro A
    Rev Clin Esp; 1986 Jun; 179(2):101. PubMed ID: 3738054
    [No Abstract]   [Full Text] [Related]  

  • 11. [Propafenone: a new anti-arrhythmic agent for the treatment of ventricular ectopic beats].
    Molinis G; Valente M; Tuniz D; Maisano G
    Cardiologia; 1982; 27(2):211-7. PubMed ID: 6927434
    [No Abstract]   [Full Text] [Related]  

  • 12. Propafenone for refractory ventricular arrhythmias: correlation with drug plasma levels during long-term treatment.
    Naccarella F; Bracchetti D; Palmieri M; Marchesini B; Ambrosioni E
    Am J Cardiol; 1984 Nov; 54(8):1008-14. PubMed ID: 6496321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind placebo-controlled evaluation of propafenone in suppressing ventricular ectopic activity.
    Hodges M; Salerno D; Granrud G
    Am J Cardiol; 1984 Nov; 54(9):45D-50D. PubMed ID: 6388303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Observations on the anti-arrhythmic effects of propafenone].
    Ku FS
    Zhonghua Nei Ke Za Zhi; 1982 Nov; 21(11):658-61. PubMed ID: 7166067
    [No Abstract]   [Full Text] [Related]  

  • 15. [Plasma level and effectiveness of propafenone and its organ distribution (author's transl)].
    Blanke H; Aschbrenner B; Karsch KR; Kreuzer H
    Dtsch Med Wochenschr; 1979 Apr; 104(16):587-91. PubMed ID: 86416
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of propafenon in the acute and chronic treatment of supraventricular and ventricular arrhythmias].
    Menozzi C; Lolli G; Gheller G; Monducci I; Vergoni W; Cattabiani ML; Manenti E; Casali G
    Clin Ter; 1983 Apr; 105(2):125-33. PubMed ID: 6345053
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of the hemodynamic effects and anti-arrhythmic activity of propafenone: from new frontiers to clinical verification].
    Lotto A; Finzi A
    G Ital Cardiol; 1986 Apr; 16(4):333-5. PubMed ID: 3743936
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of the electrophysiologic effects of propafenon in patients with cardiac pre-excitation].
    Disertori M; Vergara G; Inama G; Guarnerio M; Dal Forno P; Furlanello F
    Boll Soc Ital Cardiol; 1981; 26(11):1725-8. PubMed ID: 7349232
    [No Abstract]   [Full Text] [Related]  

  • 19. High-performance liquid chromatographic procedure for the quantitation of propafenone in serum and tissues.
    Kannan R; Tidwell D; Singh BN
    J Chromatogr; 1983 Feb; 272(2):428-31. PubMed ID: 6833442
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolite cumulation during chronic propafenone dosing in arrhythmia.
    Kates RE; Yee YG; Winkle RA
    Clin Pharmacol Ther; 1985 Jun; 37(6):610-4. PubMed ID: 4006362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.